Smithfield Trust’s MiMedx Group MDXG Stock Holding History

Smithfield Trust’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2K	Hold	606	–	–	﹤0.01%	1042
2026 Q1	$2K	Hold	606	–	–	﹤0.01%	1047
2025 Q4	$4K	Hold	606	–	–	﹤0.01%	1007
2025 Q3	$4K	Hold	606	–	–	﹤0.01%	973
2025 Q2	$4K	Hold	606	–	–	﹤0.01%	985
2025 Q1	$4K	Hold	606	–	–	﹤0.01%	987
2024 Q4	$5K	Hold	606	–	–	﹤0.01%	979
2024 Q3	$4K	Hold	606	–	–	﹤0.01%	962
2024 Q2	$4K	Sell	606 -114	-16%	-$802	﹤0.01%	933
2024 Q1	$5K	Hold	720	–	–	﹤0.01%	932
2023 Q4	$6K	Hold	720	–	–	﹤0.01%	911
2023 Q3	$5K	Hold	720	–	–	﹤0.01%	912
2023 Q2	$5K	Hold	720	–	–	﹤0.01%	927
2023 Q1	$2K	Hold	720	–	–	﹤0.01%	960
2022 Q4	$2K	Sell	720 -17	-2%	-$51	﹤0.01%	958
2022 Q3	$2K	Hold	737	–	–	﹤0.01%	1015
2022 Q2	$2K	Hold	737	–	–	﹤0.01%	1043
2022 Q1	$3K	Buy	+737	New	+$3.6K	﹤0.01%	1033
2018 Q1	–	Sell	-95	Closed	-$1K	–	1076
2017 Q4	$1K	Buy	+95	New	+$1.16K	﹤0.01%	1092

Other funds holding MDXG

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Smithfield Trust's MDXG Position: Q2 2026 in Review

Smithfield Trust held its MiMedx Group (MDXG) position steady in Q2 2026 at 606 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #1042.

Smithfield Trust first reported a position in MDXG in Q4 2017 and has held it in 19 quarters since. The position peaked at $6K in Q4 2023. 226 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

Smithfield Trust held 606 shares of MiMedx Group worth $2K as of Q2 2026.
Smithfield Trust left its MiMedx Group share count unchanged in Q2 2026.
MiMedx Group made up ﹤0.01% of Smithfield Trust's portfolio in Q2 2026, its #1042 holding.
Smithfield Trust first reported a position in MiMedx Group in Q4 2017 and has held it in 19 quarters since.
Smithfield Trust's MiMedx Group position peaked at $6K in Q4 2023.
226 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on Smithfield Trust's 13F filing for Q2 2026, filed 5 Aug 2026.